Bordetella bronchiseptica pneumonia in a woman with lymphoma: A case report


A 62-year-old woman with splenic marginal zone lymphoma presented with fever, cough and bilateral pneumonia 11 days after chemotherapy. A bronchoalveolar lavage showed numerous leukocytes and Gramnegative bacilli that were identified as Bordetella bronchiseptica in culture. An antibiotherapy with minocycline and ciprofloxacin helped her to stop coughing. This unusual micro-organism, which has mainly an animal reservoir, is a rarely cause of human infection, almost always in immunocompromised patients. The main problems in B. bronchiseptica infection are the difficulties of identification of this micro-organism and the recurrence of infection, which are a challenge for microbiologists and practitionners.

Share and Cite:

Delluc, A. , Hervier, B. , Le Boutin, T. , Le Coustumier, A. , Jarlier, V. , Amoura, Z. and Brossier, F. (2012) Bordetella bronchiseptica pneumonia in a woman with lymphoma: A case report. Open Journal of Internal Medicine, 2, 50-52. doi: 10.4236/ojim.2012.22011.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Bemis, D.A., Greisen, H.A. and Appel, M.J. (1977) Bacteriological variation among Bordetella bronchiseptica isolates from dogs and other species. Journal of Clinical Microbiology, 5, 471-480.
[2] Dworkin, M.S., Sullivan, P.S., Buskin, S.E., et al. (1999) Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients. Clinical Infectious Diseases, 28, 1095-1099. doi:10.1086/514761
[3] Woolfrey, B.F. and Moody, J.A. (1991) Human infections associated with Bordetella bronchiseptica. Clinical Microbiology Reviews, 4, 243-255.
[4] Wernli, D., Emonet, S., Schrenzel, J. and Harbarth, S. (2011) Evaluation of eight cases of confirmed Bordetella bronchiseptica infection and colonization over a 15-year period. Clinical Microbiology and Infection, 17, 201-203. doi:10.1111/j.1469-0691.2010.03258.x
[5] Gueirard, P., Weber, C., Le Coustumier, A. and Guiso, N. (1995) Human Bordetella bronchiseptica infection related to contact with infected animals: Persistence of bacteria in host. Journal of Clinical Microbiology, 33, 2002-2006.
[6] Parkhill, J., Sebaihia, M., Preston, A., et al. (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nature Genetics, 35, 32-40. doi:10.1038/ng1227
[7] Johnson, R. and Sneath, P.H.A. (1973) Taxonomy of Bordetella and related organisms of the families Achromobacteraceae, Brucellaceae, and Neisseriaceae. International Journal of Systematic and Evolutionary Bacteriology, 23, 381-404. doi:10.1099/00207713-23-4-381
[8] Hadley, K., Torres, A.M., Moran, J. and Schiller, B. (2009) Bordetella bronchiseptica—Beware of the dog! Peritoneal Dialysis International, 29, 670-671.
[9] Belen, O., Campos, J.M., Cogen, P.H., Jantausch, B.A. (2003) Postsurgical meningitis caused by Bordetella bronchiseptica. The Pediatric Infectious Disease Journal, 22, 380-381. doi:10.1097/01.inf.0000059766.51912.e8
[10] Mattoo, S., Miller, J.F. and Cotter, P.A. (2000) Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response. Infection and Immunity, 68, 2024-2033.
[11] Huebner, E.S., Christman, B., Dummer, S., et al. (2006) Hospital-acquired Bordetella bronchiseptica infection following hematopoietic stem cell transplantation. Journal of Clinical Microbiology, 44, 2581-2583. doi:10.1128/JCM.00510-06
[12] Bauwens, J.E., Spach, D.H., Schacker, T.W., et al. (1992) Bordetella bronchiseptica pneumonia and bacteremia following bone marrow transplantation. Journal of Clinical Microbiology, 30, 2474-2475.
[13] López-Boado, Y.S., Cobb, L.M. and Deora, R. (2005) Bordetella bronchiseptica flagellin is a proinflammatory determinant for airway epithelial cells. Infection and Immunity, 73, 7525-7534. doi:10.1128/IAI.73.11.7525-7534.2005
[14] Pilione, M.R. and Harvill, E.T. (2006) The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infection and Immunity, 74, 1043-1049. doi:10.1128/IAI.74.2.1043-1049.2006
[15] Lartigue, M.F., Poirel, L., Fortineau, N. and Nordmann, P. (2005) Chromosome-borne class A BOR-1 beta-Lactamase of Bordetella bronchiseptica and Bordetella parapertussis. Antimicrobial Agents and Chemotherapy, 49, 2565-2567. doi:10.1128/AAC.49.6.2565-2567.2005

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.